identified TPT1 as a potential prognostic marker in breast cancer, emphasising its role in regulating the p53 signalling pathway and reprogramming tumour cell phenotypes, acting as a critical regulator of cancer stem cell function and tumour reversal. Here, TP53 is linked to breast carcinoma.